Bold Therapeutics to Participate in 2026 Metals in Medicine Gordon Research Conference
VANCOUVER, BC, June 22, 2026 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics is headed to the prestigious 2026 Metals in Medicine Gordon Research Conference this week in Andover, New Hampshire....
VANCOUVER, BC, June 22, 2026 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics is headed to the prestigious 2026 Metals in Medicine Gordon Research Conference this week in Andover, New Hampshire....
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.